Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

KaloBios Pharmaceuticals Inc (OTCQB:KBIO)

1.99
Delayed Data
As of Jun 27
 -0.03 / -1.49%
Today’s Change
1.51
Today|||52-Week Range
6.00
-48.97%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues44.0K0.000.000.00
 
 
Depreciation And Amortization298.0K310.0K197.0K102.0K
 
 
 
 
 
 
Operating ExpensesGross Income---310.0K-197.0K-102.0K
 
 
 
 
General Expenses40.7M36.4M28.6M18.7M
 
 
 
 
 
Research And Development32.6M26.6M15.6M10.4M
 
 
 
 
 
Total Operating Expenses41.0M36.7M28.8M18.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-40.9M-36.7M-28.8M-18.8M
 
 
 
 
 
Extraordinary Charge0.000.00-5.8M-8.2M
 
 
 
Interest Expense On Debt1.1M1.2M842.0K131.0K
 
 
 
 
 
Other Expenses-39.0K-154.0K100.0K125.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-41.9M-38.0M-35.4M-27.0M
 
 
 
 
 
Net Income-41.9M-38.0M-35.4M-27.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.0M4.1M4.1M9.7M
 
 
 
 
 
Shares To Calculate EPS Diluted3.0M4.1M4.1M9.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$13.84-$9.20-$8.57-$2.78
 
 
 
 
 
EPS Diluted-$13.84-$9.20-$8.58-$2.78